Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

mRNA-1010 quadrivalent flu vaccine shows promise in Phase I study

EuropeanPharmaceuticalReviewDecember 15, 2021

Tag: Moderna , mRNA-1010 , flu vaccine

PharmaSources Customer Service